Are 14-3-3 Proteins Important Antigens in Large Vessel Vasculitis?

Cleveland Clinic Rheumatology

L. Calabrese, G. Hoffman

CNS Vasculitis: Diagnostic Update

Cleveland Clinic Rheumatology

L. Calabrese

GCA & Steroid Weaning

RheumNow

J. Cush

Pathergy in Patients with Bechet's Disease Receiving Laser Hair Remo…

Evidence-Based Hair

J. Donovan

Giant Cell Arteritis in the Arab Region With a Focus on Jordan

Fatima Al Naimat

Great Debate (PMR/GCA) - Upfront Use of IL-6 Inhibitors

Hospital for Special Surgery

R. Spiera, P. Seo

New and Emerging Treatments in Cutaneous Vasculitis

Cleveland Clinic Rheumatology

C. Langford

Behcet Syndrome Update: How Does It Manifest? When Do Symptoms Typic…

Yusuf Yazici

Abstract Discussions: Osteoporotic Fractures in Postmenopausal Women…

RheumNow

J. Pope

Behçet Syndrome Diagnosis: How and When Do Major/Minor Clinical Mani…

Haner Direskeneli

72 y/o Female With Giant Cell Arteritis, Polymyalgia Rheumatica, and…

Vanderbilt University Medical Center (VUMC)

K. Byram

When Should Biologic Agents be Introduced in Giant Cell Arteritis an…

Cleveland Clinic Rheumatology

K. Warrington

Introduction to Ultrasound in Large Vessel Vasculitis - How to Corre…

University of Washington School of Medicine

W. Schmidt

Are There Factors That Can Guide Treatment Decisions in Newly Diagno…

Cleveland Clinic Rheumatology

A. Villa-Forte

GI Manifestations of Rheumatologic Disorders in Women

Jefferson Health

C. Choudhary

EULAR® 2024 Insights: Ultrasound of Peripheral Arteries in GCA

EULAR® 2024 Insights

W. Schmidt

EADV Highlights: IgA Associated Vasculitis

Hok Bing Thio

Cleveland Clinic 2020 ACR Update on GCA: Is Tocilizumab + Ultra-Shor…

Cleveland Clinic Rheumatology and Immunology Series

A. Brown

ACR Convergence 2023 Highlights: Tocilizumab vs Methotrexate in Gian…

Highlights from ACR Convergence 2023

E. Treppo

Rheumatic IO Related irAEs: Are Rheumatogists Best Equipped to Manag…

Cleveland Clinic Rheumatology

L. Calabrese